J Clin Neurol.  2016 Jan;12(1):115-116. 10.3988/jcn.2016.12.1.115.

Neurological Involvement in Erdheim-Chester Disease

Affiliations
  • 1Department of Neurology, Salamanca University Healthcare Complex, Salamanca, Spain.
  • 2Department of Internal Medicine, Salamanca University Healthcare Complex, Salamanca, Spain. jpmiramontes@hotmail.com
  • 3IBSAL (Instituto de investigacionesBiomedicas de Salamanca), Salamanca, Spain.

Abstract

No abstract available.


MeSH Terms

Erdheim-Chester Disease*

Figure

  • Fig. 1 Brain MRI. A: An axial, T1-weighted cranial MRI image obtained after administering intravenous contrast medium, the arrow point the epidural enhancement on the frontal lobe. B: A coronal, T1-weighted cranial MRI image showing an infiltrating-like lesion on the left anterior cranial fossa with involvement of the apex, sphenoid fissure, and cavernous sinus. A polypoid lesion on the left nasal fossa can also be seen.


Reference

1. Arnaud L, Hervier B, Néel A, Hamidou MA, Kahn JE, Wechsler B, et al. CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011; 117:2778–2782.
Article
2. Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013; 8:137.
Article
3. Perez A, Crahes M, Laquerrière A, Proust F, Derrey S. Neurological form of Erdheim-Chester disease: case report and review of the literature. Neurochirurgie. 2014; 60:316–320.
Article
4. Cuello-Oderiz C, Pigretti S, Patrucco L. [Neurological onset of Erdheim-Chester disease]. Rev Neurol. 2014; 59:572–574.
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr